{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:09:05Z","timestamp":1773882545021,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the national institutes of health, fogarty international center","award":["2D43TW007296"],"award-info":[{"award-number":["2D43TW007296"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Voodoo is a heterogeneous mixture of psychoactive substances that has recently grown in popularity among youth in Egypt. Patients can present with a variety of manifestations that may lead to death in some cases. This study assessed the acute toxic effects of voodoo among patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH) during a one year period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective study of all patients presented with voodoo intoxication at the PCC-ASUH from 1\u00a0January 2017 to 31 December 2017. Clinical data, routine laboratory findings, and ECG results as well as duration of hospitalization and outcome were compiled from hospital records.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventy-one voodoo intoxication cases meeting the inclusion criteria were analyzed (mean age: 25.19\u2009\u00b1\u20099.54 years, range: 15\u201350 years, 97.2\u2009% male). Pulse, blood pressure, and respiratory rate were normal in more than half of all patients. Neurological abnormalities including agitation, hallucinations, disturbance of consciousness were the most frequent manifestations. Respiratory acidosis was the most common laboratory finding (54.9\u2009%), followed by increased serum urea (43.6\u2009%), hypokalemia (33.8\u2009%), hyperglycemia (28.1\u2009%), and leukocytosis (26.7\u2009%). The most common ECG finding was sinus tachycardia (31\u2009%), followed by QT prolongation (15.4\u2009%). More than half of the studied patients (53.5\u2009%) co-administered other illicit substances, most frequently cannabis and tramadol. Most patients recovered fully and were discharged, but death occurred in two cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Voodoo toxicity can manifest with many presentations, hampering timely diagnosis. Clinicians should consider possible voodoo poisoning in patients presenting with a history of drug use with neurological symptoms, and they should conduct follow-up arterial blood gases, electrolytes and ECG as voodoo may contain potentially fatal psychoactive substances.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13011-021-00408-4","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T15:03:05Z","timestamp":1632150185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acute Toxic Effects of the New Psychoactive Substance \u201cVoodoo\u201d among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-2474","authenticated-orcid":false,"given":"Rania","family":"Hussien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maged","family":"El-Setouhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed El","family":"Shinawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem Mohamed","family":"El-Hariri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Mark","family":"Hirshon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"issue":"4","key":"408_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/brainsci8040058","volume":"8","author":"R Gittins","year":"2018","unstructured":"Gittins R, Guirguis A, Schifano F, et al. Exploration of the use of new psychoactive substances by individuals in treatment for substance misuse in the UK. Brain Sci. 2018;8(4):58.","journal-title":"Brain Sci"},{"key":"408_CR2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). New psychoactive substances in Europe. An update from the EU Early Warning System. Available at: http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att 235958 EN TD0415135ENN.pdf (accessed on 23.04.15)."},{"issue":"4","key":"408_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/YCO.0000000000000071","volume":"27","author":"E Papaseit","year":"2014","unstructured":"Papaseit E, Farr\u00e9 M, Schifano F, et al. Emerging drugs in Europe. Curr Opin Psychiatry. 2014;27(4):243\u201350.","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"408_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s13181-012-0241-3","volume":"8","author":"DM Wood","year":"2012","unstructured":"Wood DM, Dargan PI. Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. J Med Toxicol. 2012;8(3):300\u20133.","journal-title":"J Med Toxicol"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.20471\/may.2018.54.01.01","volume":"54","author":"RG Tkalic","year":"2017","unstructured":"Tkalic RG. Use of new psychoactive substances among the general population in Croatia: patterns of use and sociodemographic characteristics of users. Alcohol Psychiatry Res. 2017;54:5\u201320.","journal-title":"Alcohol Psychiatry Res"},{"key":"408_CR6","volume-title":"World Drug Report 2017","author":"UNODC","year":"2017","unstructured":"UNODC. World Drug Report 2017. Vienna: United Nations Publications; 2017."},{"issue":"9","key":"408_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3109\/15563650.2015.1088157","volume":"53","author":"AM Dines","year":"2015","unstructured":"Dines AM, Wood DM, Yates C, et al. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Clin Toxicol. 2015;53(9):893\u2013900.","journal-title":"Clin Toxicol"},{"key":"408_CR8","doi-asserted-by":"crossref","unstructured":"Assi S, Gulyamova N, Ibrahim K, et al. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies. Hum Psychopharmacol. 2017;32(3).","DOI":"10.1002\/hup.2607"},{"issue":"1","key":"408_CR9","first-page":"1","volume":"4","author":"E Hamdi","year":"2016","unstructured":"Hamdi E, Sabry N, Sedrak A, et al. Sociodemographic indicators for substance use and abuse in Egypt. J Addict Prev. 2016;4(1):1\u20138.","journal-title":"J Addict Prev"},{"issue":"4","key":"408_CR10","first-page":"1","volume":"27","author":"M Rabie","year":"2020","unstructured":"Rabie M, Shaker NM, Gaber E, et al. Prevalence updates of substance use among Egyptian adolescents. Middle East Curr Psychiatry. 2020;27(4):1\u20138.","journal-title":"Middle East Curr Psychiatry"},{"issue":"1","key":"408_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/1874944502013010425","volume":"13","author":"AMM Hashim","year":"2020","unstructured":"Hashim AMM, Hassan AM, Amin GE, et al. Prevalence of Strox Smoking Among University Students in Cairo, Egypt. The Open Public Health Journal. 2020;13(1):425\u20139. DOI:https:\/\/doi.org\/10.2174\/1874944502013010425.","journal-title":"The Open Public Health Journal"},{"key":"408_CR12","doi-asserted-by":"publisher","unstructured":"Hussien R, Ahmed S, Awad H, et al. Identification of \u201cVoodoo\u201d: an emerging substance of abuse in Egypt. Int J Environ Anal Chem. 2020:1\u201313. DOI: https:\/\/doi.org\/10.1080\/03067319.2020.1715384.","DOI":"10.1080\/03067319.2020.1715384"},{"key":"408_CR13","unstructured":"Poison Control Center of Ain Shams University Hospitals (PCC-ASUH). Records 2016."},{"issue":"2","key":"408_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0976-500X.81895","volume":"2","author":"S Parasuraman","year":"2011","unstructured":"Parasuraman S. Toxicological screening. J Pharmacol Pharmacother. 2011;2(2):74\u20139.","journal-title":"J Pharmacol Pharmacother"},{"key":"408_CR15","unstructured":"Royal College of Nursing. (2017) Standards for Assessing, Measuring and Monitoring, Vital Signs in Infants, Children and Young People, London: RCN. Available at: https:\/\/www.rcn.org.uk\/professionaldevelopment\/publications\/pub-005942."},{"key":"408_CR16","first-page":"353","volume":"7","author":"HC Bazett","year":"1920","unstructured":"Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353\u201370.","journal-title":"Heart"},{"issue":"2","key":"408_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/08897077.2012.677752","volume":"34","author":"E Hamdi","year":"2013","unstructured":"Hamdi E, Gawad T, Khoweiled A, et al. Lifetime prevalence of alcohol and substance use in Egypt: A community survey. Subst Abus. 2013;34(2):97\u2013104.","journal-title":"Subst Abus"},{"issue":"1","key":"408_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1037\/a0024780","volume":"121","author":"NR Eaton","year":"2012","unstructured":"Eaton NR, Keyes KM, Krueger RF, et al. An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. J Abnorm Psychol. 2012;121(1):282\u20138.","journal-title":"J Abnorm Psychol"},{"issue":"1\u20133","key":"408_CR19","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.forsciint.2010.12.014","volume":"206","author":"KJ Lusthof","year":"2011","unstructured":"Lusthof KJ, Oosting R, Maes A, et al. A case of extreme agitation and death after the use of mephedrone in the Netherlands. Forensic Sci Int. 2011;206(1\u20133):e93\u20135.","journal-title":"Forensic Sci Int"},{"issue":"6","key":"408_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/15563650.2011.590812","volume":"49","author":"HA Spiller","year":"2011","unstructured":"Spiller HA, Ryan ML, Weston RG, Jansen J. Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States. Clin Toxicol (Phila). 2011;49(6):499\u2013505.","journal-title":"Clin Toxicol (Phila)"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.forsciint.2014.02.022","volume":"243","author":"A Helander","year":"2014","unstructured":"Helander A, B\u00e4ckberg M, Hult\u00e9n P, et al. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int. 2014;243:23\u20139.","journal-title":"Forensic Sci Int"},{"issue":"5","key":"408_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/bjaed\/mkw068","volume":"17","author":"G Dignam","year":"2017","unstructured":"Dignam G, Bigham C. Novel psychoactive substances: a practical approach to dealing with toxicity from legal highs. BJA Educ. 2017;17(5):172\u20137.","journal-title":"BJA Educ"},{"key":"408_CR23","first-page":"58","volume":"4","author":"M Prilutskaya","year":"2017","unstructured":"Prilutskaya M, Elgharably Y, Corazza O. Current challenges of synthetic cannabinoids: clinical and psychopathological aspects. Res Adv Psychiatry. 2017;4:58\u201363.","journal-title":"Res Adv Psychiatry"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/15563650.2018.1547826","volume":"57","author":"BP Murray","year":"2019","unstructured":"Murray BP, Carpenter JE, Dunkley CA, et al. Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone. Clin Toxicol. 2019;57:692\u20136.","journal-title":"Clin Toxicol"},{"key":"408_CR25","first-page":"137","volume":"22","author":"MH Alon","year":"2017","unstructured":"Alon MH, Saint-Fleur MO. Synthetic cannabinoid induced acute respiratory depression: case series and literature review. Respir Med Case Rep. 2017;22:137\u201341.","journal-title":"Respir Med Case Rep"},{"issue":"1","key":"408_CR26","first-page":"e14","volume":"8","author":"B Dadpour","year":"2020","unstructured":"Dadpour B, Alizadeh A, Vahabzadeh M, et al. Arterial blood gas analysis of patients with tramadol-induced seizure; a cross sectional study. Arch Acad Emerg Med. 2020;8(1):e14.","journal-title":"Arch Acad Emerg Med"},{"issue":"4","key":"408_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/npp.2017.181","volume":"43","author":"E Solis","year":"2018","unstructured":"Solis E, Cameron-Burr KT, Shaham Y, Kiyatkin EA. Fentanyl-induced brain hypoxia triggers brain hyperglycemia and biphasic changes in brain temperature. Neuropsychopharmacology. 2018;43(4):810\u20139.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"408_CR28","doi-asserted-by":"publisher","first-page":"e22702","DOI":"10.5812\/ijhrba.22702","volume":"4","author":"DB Sanli","year":"2015","unstructured":"Sanli DB, Bilici R, Suner O, et al. Effect of different psychoactive substances on serum biochemical parameters. Int J High Risk Behav Addict. 2015;4(2):e22702.","journal-title":"Int J High Risk Behav Addict"},{"issue":"9","key":"408_CR29","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/ndt\/gft023","volume":"28","author":"GD van Dijken","year":"2013","unstructured":"van Dijken GD, Blom RE, Hen\u00e9 RJ, et al. High incidence of mild hyponatraemia in females using ecstasy at a rave party. Nephrol Dial Transplant. 2013;28(9):2277\u201383.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"408_CR30","first-page":"487","volume":"92","author":"AJ Viera","year":"2015","unstructured":"Viera AJ, Wouk N. Potassium disorders: hypokalemia and hyperkalemia. Am Fam Phys. 2015;92(6):487\u201395.","journal-title":"Am Fam Phys"},{"issue":"4","key":"408_CR31","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.5455\/medscience.2014.03.8172","volume":"3","author":"B Taskiran","year":"2014","unstructured":"Taskiran B, Mutluay R. A case of hypokalemia with synthetic cannabinoid use. Med-Science. 2014;3(4):1713\u20138.","journal-title":"Med-Science"},{"issue":"4","key":"408_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1152\/advan.90185.2008","volume":"32","author":"AR Mehta","year":"2008","unstructured":"Mehta AR. Why does the plasma urea concentration increase in acute dehydration? Adv Physiol Educ. 2008;32(4):336.","journal-title":"Adv Physiol Educ"},{"issue":"1","key":"408_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12882-017-0794-0","volume":"18","author":"K Mansoor","year":"2017","unstructured":"Mansoor K, Kheetan M, Shahnawaz S, et al. Systematic review of nephrotoxicity of drugs of abuse, 2005\u20132016. BMC Nephrol. 2017;18(1):379.","journal-title":"BMC Nephrol"},{"issue":"4","key":"408_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4067\/S0034-98872011000400010","volume":"139","author":"R Carrasco","year":"2011","unstructured":"Carrasco R, Salinas M, Rossel V. Rhabdomyolysis and acute renal failure after cocaine overdose: report of one case. Rev Med Chile. 2011;139(4):480\u20133.","journal-title":"Rev Med Chile"},{"issue":"5","key":"408_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1159\/000337941","volume":"21","author":"K Turgutalp","year":"2012","unstructured":"Turgutalp K, Kiykim A, Karabulut U, et al. Reversible minimal change nephrotic syndrome and glomerular IgA deposition associated with nonparenteral heroin abuse: a case report. Med Princ Pract. 2012;21(5):492\u20134.","journal-title":"Med Princ Pract"},{"issue":"12","key":"408_CR36","doi-asserted-by":"publisher","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","volume":"137","author":"G Ostapowicz","year":"2002","unstructured":"Ostapowicz G, Fontana RJ, Schi\u00f8dt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947\u201354.","journal-title":"Ann Intern Med"},{"issue":"8","key":"408_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0210-5705(02)70299-9","volume":"25","author":"O N\u00fa\u00f1ez","year":"2002","unstructured":"N\u00fa\u00f1ez O, Ba\u00f1ares R, Barrio J, et al. Variability of the clinical expression of ecstasy-induced hepatotoxicity. Gastroenterol Hepatol. 2002;25(8):497\u2013500.","journal-title":"Gastroenterol Hepatol"},{"issue":"9","key":"408_CR38","first-page":"855","volume":"19","author":"HR Rahimi","year":"2014","unstructured":"Rahimi HR, Soltaninejad K, Shadnia S. Acute tramadol poisoning and its clinical and laboratory findings. J Res Med Sci. 2014;19(9):855\u20139.","journal-title":"J Res Med Sci"},{"issue":"4","key":"408_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4103\/0974-2700.70766","volume":"3","author":"F Yousef Khan","year":"2010","unstructured":"Yousef Khan F, Yousef H, Errayes M. Tramadol toxicity-induced rhabdomyolysis. J Emerg Trauma Shock. 2010;3(4):421\u20132.","journal-title":"J Emerg Trauma Shock"},{"issue":"2","key":"408_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13181-014-0451-y","volume":"11","author":"AD O\u2019Connor","year":"2015","unstructured":"O\u2019Connor AD, Padilla-Jones A, Gerkin RD, Levine M. Prevalence of rhabdomyolysis in sympathomimetic toxicity: a comparison of stimulants. J Med Toxicol. 2015;11(2):195\u2013200.","journal-title":"J Med Toxicol"},{"issue":"6","key":"408_CR41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res. 2013;113(6):739\u201353.","journal-title":"Circ Res"},{"issue":"3","key":"408_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ams2.182","volume":"3","author":"Y Fujita","year":"2016","unstructured":"Fujita Y, Koeda A, Fujino Y, et al. Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones. Acute Med Surg. 2016;3(3):230\u20136.","journal-title":"Acute Med Surg"},{"issue":"7","key":"408_CR43","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jat\/bkx031","volume":"41","author":"BK Logan","year":"2017","unstructured":"Logan BK, Mohr ALA, Friscia M, et al. Reports of adverse events associated with use of novel psychoactive substances, 2013\u20132016: a review. J Anal Toxicol. 2017;41(7):573\u2013610.","journal-title":"J Anal Toxicol"},{"key":"408_CR44","doi-asserted-by":"publisher","unstructured":"Richards JR, Farias VF, Clingan CS. Association of leukocytosis with amphetamine and cocaine use. Sci World J. 2014:1\u20137. DOI: https:\/\/doi.org\/10.1155\/2014\/207651.","DOI":"10.1155\/2014\/207651"},{"key":"408_CR45","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). High-risk drug use and new psychoactive substances: results from an EMCDDA tredspotter study. http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/4540\/TD0217575ENN.pdf; 2017."},{"issue":"6","key":"408_CR46","doi-asserted-by":"publisher","first-page":"e1622","DOI":"10.1542\/peds.2010-3823","volume":"128","author":"A Mir","year":"2011","unstructured":"Mir A, Obafemi A, Young A, et al. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128(6):e1622\u20137.","journal-title":"Pediatrics"},{"key":"408_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/542490","volume":"2015","author":"J Orsini","year":"2015","unstructured":"Orsini J, Blaak C, Tam E, et al. The wide and unpredictable scope of synthetic cannabinoids toxicity. Case Rep Crit Care. 2015;2015:1\u20135. DOI:https:\/\/doi.org\/10.1155\/2015\/542490.","journal-title":"Case Rep Crit Care"},{"key":"408_CR48","first-page":"120607","volume":"2014","author":"S Ibrahim","year":"2014","unstructured":"Ibrahim S, Al-Saffar F, Wannenburg T. A Unique Case of Cardiac Arrest following K2 Abuse. Case Rep Cardiol. 2014;2014:120607.","journal-title":"Case Rep Cardiol"},{"issue":"1","key":"408_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13181-014-0424-1","volume":"11","author":"RG McKeever","year":"2015","unstructured":"McKeever RG, Vearrier D, Jacobs D, et al. K2\u2013not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report. J Med Toxicol. 2015;11(1):129\u201331.","journal-title":"J Med Toxicol"},{"issue":"1","key":"408_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000050712","volume":"7","author":"M Backmund","year":"2001","unstructured":"Backmund M, Meyer K, Zwehl W, et al. Myocardial infarction associated with methadone and\/or dihydrocodeine. Eur Addict Res. 2001;7(1):37\u20139.","journal-title":"Eur Addict Res"},{"issue":"10","key":"408_CR51","first-page":"107","volume":"44","author":"DG Ioseliani","year":"2004","unstructured":"Ioseliani DG, Semitko SP, Gromov DG, et al. Development of transmural myocardial infarction in young persons with intact coronary arteries during methadone use for the treatment of heroine addiction. Kardiologiia. 2004;44(10):107\u201312.","journal-title":"Kardiologiia"},{"key":"408_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","volume":"144","author":"MS Castaneto","year":"2014","unstructured":"Castaneto MS, Gorelick DA, Desrosiers NA, et al. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12\u201341.","journal-title":"Drug Alcohol Depend"},{"key":"408_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.21608\/ajfm.2018.15880","volume":"31","author":"HK khalifa","year":"2018","unstructured":"khalifa HK, Lashin HI. Predictors for Intensive Care Unit Admission in Acute Theophylline Intoxicated Patients. Ain Shams J Forensic Med Clin Toxicol. 2018;31:77\u201386.","journal-title":"Ain Shams J Forensic Med Clin Toxicol"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-021-00408-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T17:18:08Z","timestamp":1632158288000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-021-00408-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s13011-021-00408-4","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"8 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Boards of Ain Shams University and the University of Maryland, Baltimore, approved the protocol before study initiation. All collected data were anonymous and kept confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}